REDO-JAK trial
In the REDO-JAK trial (Dose REDuction Of JAK inhibitors in patients with inflammatory rheumatic diseases) we investigate if a step-by-step dose reduction is feasible for JAK inhibitor users with low disease activity.
In the REDO-JAK trial (Dose REDuction Of JAK inhibitors in patients with inflammatory rheumatic diseases) we investigate if a step-by-step dose reduction is feasible for JAK inhibitor users with low disease activity.